MedPath

Minder hinder na een epileptische aanval

Recruiting
Conditions
EpilepsyElectroconvulsive therapyPostictal stateAcetaminophenNimodipineHypoperfusionEpilepsieElektroconvulsietherapiePostictale faseParacetamolNimodipineHypoperfusie
Registration Number
NL-OMON26656
Lead Sponsor
niversity of Twente, Enschede; Rijnstate Hospital, Arnhem
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
33
Inclusion Criteria

Adulthood (age > 17 years);

Current clinical diagnosis of depressive episode (unipolar, bipolar, schizoaffective);

Exclusion Criteria

Known adverse reactions to acetaminophen or nimodipine. In that case participants can still be included into the other intervention groups;

Chronic use of acetaminophen, calcium-antagonists or NSAID’s that cannot be interrupted for less than two days before the ECT-session.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure will be ‘time to EEG normalization’, defined as the time interval between seizure onset and return to the pre-ECT (baseline) EEG, quantified with the temporal Brain Symmetry Index. This is a well-defined, robust and generally accepted quantitative metric of EEG background evolution over time.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath